SOURCE: Proove Biosciences, Inc.

Proove Biosciences, Inc.

July 21, 2016 13:23 ET

Brian Meshkin Named Emerging Technology CEO Finalist for Orange County Technology Alliance Innovation Awards

Founder of Leading Healthcare Decision-Making Company Recognized as Pioneer in Personalized Medicine

IRVINE, CA--(Marketwired - Jul 21, 2016) - Proove Biosciences, Inc. is proud to announce that its founder and CEO, Brian Meshkin, has been named an Emerging Technology CEO finalist in the Orange County Technology Alliance's 2016 High-Tech Innovation Awards. Meshkin is among a select group of highly respected Orange County innovators invited to participate in this premier awards event in the Southern California technology community. Now in its 23rd year, the OC Tech Alliance awards celebrate achievement and honor local companies, leaders and technologies that make Orange County a tech innovation hub.

"I am honored and humbled by this selection as a finalist," says Meshkin, the pioneering founder of Proove Biosciences, whose mission is to address and resolve the challenges involved in the nation's largest and most costly health condition -- pain. "When we began this journey in 2009, we had a simple -- albeit herculean -- goal to alleviate suffering from opioid addiction and pain. Recognition from fellow business leaders and technology executives like the OC Tech Alliance not only serves as confirmation that we are on the right path, but also adds to an ever-increasing number of organizations and individuals validating Proove's groundbreaking approach to personalizing medicine."

In collaboration with top medical and scientific advisors, Proove Biosciences has emerged as the commercial and educational leader in the research, investigation and development of patent-protected tests that combine genetic and clinical data into reports that enable physicians to individualize -- and optimize -- medicine selection and dosing. With a patented bioinformatics platform that delivers therapy-defining information, prescribers are enabled to evaluate pain tolerance, identify risk for opioid dependence and addiction, predict response and immunity to opioid and non-opioid pain medication, and assess patient drug metabolism.

"Particularly at a time when opioid addiction and overdose has taken center stage in America, we are passionate about and committed to finding solutions to improve outcomes for pain prescribers, patients and insurers alike," adds Meshkin, a 20-year industry veteran who has been the recipient of numerous awards and recognitions, including finalist of the 2015 and 2016 Ernst & Young Entrepreneur of the Year Award and winner of the 2016 Orange County Business Journal Excellence in Entrepreneurship Award. "By replacing trial-and-error approaches with technologically advanced solutions that facilitate accurate and evidence-based medical decision-making, Proove is helping reduce the risk of treatment failure and relieving society of the emotional and financial burdens associated with pain and opioid addiction."

Over the past 22 years, the High-Tech Innovation Awards have recognized more than 450 innovators, technology executives and outstanding technology companies based in Orange County. This year's winners will be announced at a gala on October 6, 2016 at the Westin South Coast Plaza. To purchase tickets, visit: www.octechalliance.com.

To learn more about Proove Biosciences, visit www.proove.com. With media inquiries, please contact Leslie Licano at leslie@beyondfifteen.com or (949)-733-8679.

About Proove Biosciences: Proove Biosciences -- the Healthcare Decision Company™ -- is the commercial and educational leader in the research, investigation and development of patent-protected tests that combine genetic and clinical data into reports to help physicians to individualize -- and optimize -- medicine selection and dosing. Supported by leading medical experts and institutions across the globe, the reports facilitate objective decision-making to improve outcomes for patients, providers and insurers. Backed by science and driven by data, Proove is revolutionizing individualized medicine. With a patented bioinformatics platform that delivers therapy-defining information that allows prescribers to evaluate pain tolerance, identify risk for dependence and addiction, predict response and immunity to opioid and non-opioid pain medication, and assess patient drug metabolism, Proove provides the most technologically advanced solutions to enable accurate and evidence-based medical decision-making rather than "trial-and-error" approaches. Proove helps reduce the risk of treatment failure, decrease costs to insurers and relieve society of the emotional and financial burdens associated with addiction and other avoidable consequences. For more information, please visit www.proove.com or call toll free 855-PROOVE-BIO (855-776-6832).

About Orange County Technology Alliance
The Orange County Technology Alliance (OC Tech Alliance) is a 501(c)6 nonprofit trade association committed to fast-forwarding the local innovation economy. It is the successor organization to the Orange County Council of TechAmerica and AeA. It is the only technology association addressing the needs of small-to-midsize technology companies and their leaders based in Orange County, Calif. The alliance serves members through local networking, professional development, state and federal advocacy, savings on business services and industry recognition. To learn more about membership, contact OC Tech Alliance octech@octechalliance.com or www.octechalliance.com. Follow alliance activities on Twitter at www.twitter.com/octechalliance.

Contact Information